Cover image of the article: Non-alcoholic steatohepatitis: An update in pathophysiology, diagnosis and therapy

Image Credit:Hepat Mon

Non-alcoholic steatohepatitis: An update in pathophysiology, diagnosis and therapy

Authors

Hossein Khedmat1,*, Saeed Taheri2
1Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Khedmat.h@gmail.com, IR.Iran
2Dr. Taheri Medical Research Group, IR.Iran
*Corresponding Author: Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Khedmat.h@gmail.com, IR.Iran. Tel: +98-2188964763. Fax: +98-2181262072. Email: Khedmat.h@gmail.com

Hepatitis Monthly:Vol. 11, issue 2; 74-85
Published online:Feb 28, 2011
Article type:Review Article
Received:May 23, 2010
Accepted:Aug 27, 2010
How to Cite:Khedmat H, Taheri S. Non-alcoholic steatohepatitis: An update in pathophysiology, diagnosis and therapy. Hepat Mon. 2011;11(2):. doi:

Abstract

Non-alcoholic steatohepatitis (NASH), first described by Ludwig et al, in 1980, is a stage in the wide spectrum of non-alcoholic fatty liver diseases (NAFLDs) and one of the leading causes of chronic liver disease. Several scientists have tried to more distinctly discover and describe different aspects of NASH. In contrast with its counterpart in the NAFLDs-the NAFL-NASH consists of inflammation as well as necrosis in the liver tissue resulting in a poor outcome. NASH is also a known etiology for cryptogenic liver cirrhosis. Evidence suggests that cirrhosis developing due to NASH have a relatively worse outcome compared to that of hepatitis C-related cirrhosis. In this review article, we try to review and present all relevant articles about NASH.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

28
Jun
2022
Non-alcoholic Steatohepatitis Diagnosis and Treatment Medical and Surgery, Based on Guideline Updates: A Mini Review

Non-alcoholic Steatohepatitis Diagnosis and Treatment Medical and Surgery, Based on Guideline Updates: A Mini Review

Mohsen Arabi,
Raheleh Alimoradzadeh,
Alireza Makian,
Seyed Javad Shariat Nabavi,
Farshad Divsalar,
Mitra Kazemi Jahromi

Arabi M, Alimoradzadeh R, Makian A, Shariat Nabavi SJ, Divsalar F, et al. Non-alcoholic Steatohepatitis Diagnosis and Treatment Medical and Surgery, Based on Guideline Updates: A Mini Review. J Health Rep Technol. 2022;8(3):e119454. doi: https://doi.org/10.5812/jhrt-119454

20
Apr
2019
Outcomes of Non-Alcoholic Steatohepatitis Patients After Liver Transplantation: A Systematic Review and Meta-Analysis

Outcomes of Non-Alcoholic Steatohepatitis Patients After Liver Transplantation: A Systematic Review and Meta-Analysis

Yu Zhao,
Xiaoguang Zhan,
Yan Zhang

Zhao Y, Zhan X, Zhang Y. Outcomes of Non-Alcoholic Steatohepatitis Patients After Liver Transplantation: A Systematic Review and Meta-Analysis. Hepat Mon. 2019;19(4):e82336. doi: https://doi.org/10.5812/hepatmon.82336

10
Nov
2013
Non-Alcoholic Fatty Liver Disease: Diagnosis and Evaluation of Disease Severity

Non-Alcoholic Fatty Liver Disease: Diagnosis and Evaluation of Disease Severity

Raika Jamali

Jamali R. Non-Alcoholic Fatty Liver Disease: Diagnosis and Evaluation of Disease Severity. Thrita J Neu. 2013;2(4):43-51. doi: https://doi.org/10.5812/thrita.11795

1
May
2014
Nonalcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Childhood: Endocrine-Metabolic “Mal-Programming”

Nonalcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Childhood: Endocrine-Metabolic “Mal-Programming”

Sara Manti,
Claudio Romano,
Valeria Chirico,
Martina Filippellii,
Caterina Cuppari,
Italia Loddo
,et al.

Manti S, Romano C, Chirico V, Filippellii M, Cuppari C, et al. Nonalcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Childhood: Endocrine-Metabolic “Mal-Programming”. Hepat Mon. 2014;14(5):e93068. doi: https://doi.org/10.5812/hepatmon.17641

3
Mar
2009
Clinico- biochemical comparison of patients with Nonalcoholic fatty liver disease and healthy populace

Clinico- biochemical comparison of patients with Nonalcoholic fatty liver disease and healthy populace

Manoucher Khoshbaten,
E Fatahi,
H Soomi,
m Tarzmani,
S Farhang,
G Majidi
,et al.

Khoshbaten M, Fatahi E, Soomi H, Tarzmani M, Farhang S, et al. Clinico- biochemical comparison of patients with Nonalcoholic fatty liver disease and healthy populace. Zahedan J Res Med Sci. 2009;11(1):e94431. doi:

More by these authors

Hossein KhedmatPubMedScholar
Saeed TaheriPubMedScholar
Share
Cited by
Metrics